Heart and systemic sclerosis—findings from a national cohort studyAlexis F. Guédon, Sébastien Rivière, P. Jégo et al.|Lara D. Veeken|2023Cited by 11
Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort studyBenjamin Chaigne, Alexandre Bense, C. Agard et al.|Journal of Internal Medicine|2023Cited by 7
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)F. Barde, Benjamin Chaigne, Kévin Chevalier et al.|Journal of Autoimmunity|2025Cited by 4
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysisAlexis F. Guédon, Sébastien Rivière, Fabrice Carrat et al.|RMD Open|2024Cited by 4
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, F. Aubourg et al.|Journal of Autoimmunity|2025Cited by 3